Impact of hospital-wide infection rate, invasive procedures use and antimicrobial consumption on bacterial resistance inside an intensive care unit
| Autor: | R. P. Dos Santos, Thalita Silva Jacoby, Leila Beltrami Moreira, P. Guzatto, Ricardo de Souza Kuchenbecker, Lucas Magedanz |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Adult
Male Microbiology (medical) medicine.medical_specialty Adolescent Ceftazidime Drug resistance Meropenem Microbiology law.invention Young Adult Antibiotic resistance law Internal medicine Drug Resistance Bacterial Prevalence medicine Humans Aged Antibacterial agent Aged 80 and over Cross Infection Bacteria biology business.industry Bacterial Infections General Medicine Middle Aged Acinetobacter biology.organism_classification Intensive care unit Drug Utilization Anti-Bacterial Agents Intensive Care Units Infectious Diseases Surgical Procedures Operative Female business medicine.drug Piperacillin |
| Zdroj: | Journal of Hospital Infection. 75:23-27 |
| ISSN: | 0195-6701 |
| DOI: | 10.1016/j.jhin.2009.11.021 |
| Popis: | We performed a 30-month ecological study to determine the impact of hospital-wide antibiotic consumption, invasive procedure use and hospital-acquired infections (HAIs) on antibiotic resistance in an intensive care unit (ICU). Microbiological isolates from ICU patients with established diagnosis of hospital infection were monitored throughout the study. Overall hospital consumption per 100 patient-days of piperacillin-tazobactam, fluoroquinolones and cephalosporins increased from 1.9 to 2.3 defined daily doses (DDD) (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect